Protein tyrosine phosphatase 1B (PTP1B) plays a crucial role in negatively regulating insulin and leptin signaling pathways, making PTP1B inhibitors potential novel therapeutics for type 2 diabetes and obesity. This evidence concerns the gene PTPN1 and obesity due to melanocortin 4 receptor deficiency.